TP53 and cancer: ,21 In cancer, there is an increasing repertoire of molecules that have been identified to interact with or are regulated by KPF (e.g., p53, estrogen receptor, bax/bad, STAT3, caspases) that ultimately mediate antiproliferative, pro-apoptotic, pro-oxidant (i.e., ROS production) and cell cycle-arresting effects.